Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback